VBI hepatitis B vaccine meets main goals in late-stage trial

49

VBI Vaccines Inc said on Monday a late-stage study testing its hepatitis B vaccine against GlaxoSmithKline’s Engerix-B met its main goals.

http://feeds.reuters.com/~r/reuters/healthNews/~3/BB5ZTYY_Cbk/vbi-hepatitis-b-vaccine-meets-main-goals-in-late-stage-trial-idUSKCN1TI0ZC

- Advertisement -